AN2 Therapeutics
ANTX
#10035
Rank
NZ$48.37 M
Marketcap
NZ$1.77
Share price
-2.73%
Change (1 day)
-12.73%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2025 (TTM): -NZ$64.78 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$90.02 Million, an increase over its 2023 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$64.78 Million-28.04%
2024 -NZ$90.02 Million-21.66%
2023 -NZ$0.12 Billion64.77%
2022 -NZ$69.74 Million95.89%
2021 -NZ$35.6 Million